Moghaddam 2011.
Methods | Double blind clinical trial | |
Participants | Population: 60 patients with femoral bone fracture Setting: Iran Date the study was conducted: not reported |
|
Interventions | Intervention: tranexamic acid 10 mg/kg bolus dose and 1 mg/kg infusion during operation Control: saline (same dose) |
|
Outcomes | Blood loss and blood transfusion. No deaths reported. | |
Notes | The report is an abstract and does not present how many patients were randomised in each group so no data can be analysed. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not enough data reported |
Allocation concealment (selection bias) | Unclear risk | Not enough data reported |
Blinding of outcome assessment (detection bias) Mortality | Unclear risk | Not enough data reported |
Blinding of outcome assessment (detection bias) Transfusion | Unclear risk | Not enough data reported |
Blinding of outcome assessment (detection bias) Complications | Unclear risk | Not enough data reported |
Incomplete outcome data (attrition bias) Mortality | Unclear risk | Not enough data reported |
Incomplete outcome data (attrition bias) Transfusion | Unclear risk | Not enough data reported |
Incomplete outcome data (attrition bias) Complication | Unclear risk | Not enough data reported |
Selective reporting (reporting bias) | Unclear risk | No protocol available |
Other bias | Unclear risk | ‐ |